Maloloy-on, Harry .
HRN: 21-12-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2022
CEFUROXIME 500MG (TAB)
11/26/2022
12/03/2022
ORAL
500mg
BID
AGE
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes